Last CNY36.86 CNY
Change Today +0.09 / 0.24%
Volume 1.8M
002550 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

changzhou qianhong biophar-a (002550) Snapshot

Open
CNY36.99
Previous Close
CNY18.39
Day High
CNY37.10
Day Low
CNY36.52
52 Week High
02/27/14 - CNY22.35
52 Week Low
11/11/13 - CNY13.42
Market Cap
5.9B
Average Volume 10 Days
3.0M
EPS TTM
CNY1.16
Shares Outstanding
320.0M
EX-Date
04/18/14
P/E TM
15.8x
Dividend
CNY0.50
Dividend Yield
1.36%
Current Stock Chart for CHANGZHOU QIANHONG BIOPHAR-A (002550)

Related News

No related news articles were found.

changzhou qianhong biophar-a (002550) Related Businessweek News

No Related Businessweek News Found

changzhou qianhong biophar-a (002550) Details

Changzhou Qianhong Bio-pharma Co.,ltd. manufactures enzymes and polysaccharide bio-pharmaceuticals. It provides APIs, tablets, capsules, granules, injections, and lyophilized powder for injection covering a category of kallidinogenase, L-asparaginase, Elastase Heparin, and LMW Heparin. The company’s principal APIs comprise heparin sodium and heparin calcium offered in injectable, topical, and crude grades; and finished formulations consist of heparin sodium injection and LMW heparin pre-filled syringe. It also offers compound digestive enzymes, including pepsine and pancreatin. The company exports its medicines primarily to Europe, North America, South America, and Southeast Asia. Changzhou Qianhong Bio-pharma Co.,ltd. was founded in 1971 and is based in Changzhou, China.

Founded in 1971

changzhou qianhong biophar-a (002550) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

changzhou qianhong biophar-a (002550) Key Developments

Changzhou Qianhong Biopharma Co.,Ltd. Announces Cash Dividend Implementation for 2013, Payable on April 18, 2014

Changzhou Qianhong Biopharma Co.,Ltd. announced cash dividend implementation of CNT 5.00 (tax included) per 10 shares for 2013. The dividend will be payable on April 18, 2014. The company announced record date as April 17, 2014 and ex-date as April 18, 2014.

Changzhou Qianhong Biopharma Co.,Ltd. Proposes Amendments to the Articles of Association of the Company

Changzhou Qianhong Biopharma Co.,Ltd. announced that at the annual general meeting to be held on April 4, 2014, the board will propose amendments to the articles of association of the company.

Changzhou Qianhong Biopharma Co.,Ltd., Annual General Meeting, Apr 04, 2014

Changzhou Qianhong Biopharma Co.,Ltd., Annual General Meeting, Apr 04, 2014., at 09:00 China Standard Time. Agenda: To consider the 2013 work report of the board of directors; to consider the 2013 work report of the supervisory committee; to consider financial resolution report; to consider profit distribution plan; to consider annual report and its summary; to consider appointment of audit firm; to consider remuneration for directors, supervisors and senior management; to consider use of idle proprietary fund and raised fund to purchase medium-term and short-term low-risk financial products; to consider use of over-raised fund to increase investment in the construction of a project and increase the investment quota for purchasing land; to consider use of over-raised fund to increase investment in the construction of a project; and to consider amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002550:CH CNY36.86 CNY +0.09

002550 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002550.
View Industry Companies
 

Industry Analysis

002550

Industry Average

Valuation 002550 Industry Range
Price/Earnings 30.7x
Price/Sales 6.6x
Price/Book 3.0x
Price/Cash Flow 30.7x
TEV/Sales 5.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHANGZHOU QIANHONG BIOPHAR-A, please visit www.qhsh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.